Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ARDM:US

6.5000 USD 0.00000.00%

As of 20:10:00 ET on 05/28/2015.

Snapshot for Aradigm Corp (ARDM)

Open: 6.6615 Day's Range: 6.5000 - 6.6615 Volume: 2,881
Previous Close: 6.5000 52wk Range: 6.1700 - 15.0000 1-Yr Rtn: -8.19%

Stock Chart for ARDM

No chart data available.
  • ARDM:US 6.5000
  • 1D
  • 1M
  • 1Y
6.5000
Interactive ARDM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ARDM

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2920
Est. EPS (USD) (12/2015) -0.6600
Est. PEG Ratio -
Market Cap (M USD) 95.86
Shares Outstanding (M) 14.75
30 Day Average Volume 4,343
Price/Book (mrq) 2.5100
Price/Sale (ttm) 2.6789
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ARDM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ARDM

Aradigm Corporation develops novel pulmonary drug delivery systems. The Company's systems are designed to enhance the delivery and effectiveness of a number of existing and development stage drugs and reduce the need for injectable drug therapy. Aradigm's principal product development programs are based on its AERx pulmonary drug delivery system.

Igor GondaPresident/CEOJuergen K FroehlichChief Medical Officer
Nancy E PecotaVP:Finance/CFO/SecretaryRobert A ReedVP:Regulatory
More Company Profile & Key Executives for ARDM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil